We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

New Study Hints At More Fosamax Problems

Law360 (July 15, 2008, 12:00 AM EDT) -- While the litigation over Fosamax continues to unfold, another clinical study has been released that suggests the osteoporosis drug may actually hinder bone growth and increase the possibility of fractures.

The study, conducted by physicians at Weill Medical College of Cornell University and published in the Journal of Orthopaedic Trauma, indicated that extended use of Fosamax and other bisphosphonates may increase the risk of femur fractures, News Inferno reported.

The study also revealed that long-term use of Fosamax can suppress bone metabolism, which reportedly restricts the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.